Manufacturers now face a rapidly evolving landscape where tariffs can shift overnight—from metals to paper to other key ...
In today’s demanding clinical development environment—marked by complex protocols, tightened budgets, and heightened scrutiny from regulators, payers, and patients—fragmented trial planning puts ...
Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to enhance financial flexibility and ...
AstraZeneca's $2 billion investment in Maryland will expand biologics manufacturing and establish a new clinical-stage ...
Abbott's deal shakes up cancer diagnostics, new research confirms pandemic fatigue's impact on public compliance, and more in ...
As data becomes more connected across health systems, insights evolve from static reports into living intelligence. The most ...
In the second part of his Pharma Commerce video interview, Brad Stewart, BDO’s national life sciences co leader, reveals how ...
While studies reveal the complex, varying, and long-lasting burden of Long COVID symptoms, biopharma giants Novartis and ...
Novartis is investing in a new manufacturing hub in North Carolina, enhancing US supply chain resilience and creating 700 jobs. The facilities will focus on biologics, gene therapy, and solid dosage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback